1
项与 吗替麦考酚酯/磷酸钠倍他米松 相关的临床试验A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
SURF-100 is being studied for the treatment of dry eye disease. SURF-100 is an investigational drug (which means the study drug is currently being tested) in the form of a sterile eye drop.
The purpose of this research study is to see how well SURF-100 works to treat dry eye and what potential side effects there are, and to compare it with Vehicle (placebo), 0.1% mycophenolic acid (MPA) in Vehicle, 0.3% MPA in Vehicle, 0.01% betamethasone phosphate (BSP) in Vehicle, Restasis and Xiidra. This study will involve about 280-350 study participants age 18 and older at about 40 different research sites in the United States.
100 项与 吗替麦考酚酯/磷酸钠倍他米松 相关的临床结果
100 项与 吗替麦考酚酯/磷酸钠倍他米松 相关的转化医学
100 项与 吗替麦考酚酯/磷酸钠倍他米松 相关的专利(医药)
100 项与 吗替麦考酚酯/磷酸钠倍他米松 相关的药物交易